J. Amour and J. Kersten, Diabetic Cardiomyopathy and Anesthesia, Anesthesiology, vol.108, issue.3, pp.524-554, 2008.
DOI : 10.1097/ALN.0b013e3181649369

J. Dernellis and M. Panaretou, Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients, Heart, vol.92, issue.11, pp.1645-50, 2006.
DOI : 10.1136/hrt.2005.085530

B. Hammill, L. Curtis, E. Bennett-guerrero, O. Connor, C. Jollis et al., Impact of Heart Failure on Patients Undergoing Major Noncardiac Surgery, Anesthesiology, vol.108, issue.4, pp.559-67, 2008.
DOI : 10.1097/ALN.0b013e31816725ef

G. Koh, A. Vlaar, J. Hofstra, H. De-jong, S. Van-nierop et al., In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury, Critical Care Medicine, vol.40, issue.6, pp.1835-1878, 2012.
DOI : 10.1097/CCM.0b013e31824e1696

D. Roth, C. White, C. Hamilton, J. Hall, and W. Stanley, Adrenergic desensitization in left ventricle from streptozotocin diabetic swine, Journal of Molecular and Cellular Cardiology, vol.27, issue.10, pp.2315-2340, 1995.
DOI : 10.1016/S0022-2828(95)91875-2

J. Amour, X. Loyer, L. Guen, M. Mabrouk, N. David et al., Altered Contractile Response due to Increased ??3-Adrenoceptor Stimulation in Diabetic Cardiomyopathy, Anesthesiology, vol.107, issue.3, pp.452-60, 2007.
DOI : 10.1097/01.anes.0000278909.40408.24

S. Boudina and E. Abel, Diabetic cardiomyopathy, causes and effects, Reviews in Endocrine and Metabolic Disorders, vol.150, issue.1, pp.31-40, 2010.
DOI : 10.1152/physiol.00008.2006

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914514

I. Falcão-pires and A. Leite-moreira, Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment, Heart Failure Reviews, vol.64, issue.5, pp.325-369, 2012.
DOI : 10.2165/00003495-200464050-00001

J. Amour, X. Loyer, P. Michelet, A. Birenbaum, B. Riou et al., Preservation of the Positive Lusitropic Effect of ??-Adrenoceptors Stimulation in Diabetic Cardiomyopathy, Anesthesia & Analgesia, vol.107, issue.4, pp.1130-1138, 2008.
DOI : 10.1213/ane.0b013e3181806903

V. Sharma and J. Mcneill, Parallel effects of ??-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze, World Journal of Cardiology, vol.3, issue.9, pp.281-302, 2011.
DOI : 10.4330/wjc.v3.i9.281

L. Manach, Y. Coriat, P. Collard, C. Riedel, and B. , Statin Therapy within the Perioperative Period, Anesthesiology, vol.108, issue.6, pp.1141-1147, 2008.
DOI : 10.1097/ALN.0b013e318173ef8e

V. Prinz and M. Endres, The Acute (Cerebro)Vascular Effects of Statins, Anesthesia & Analgesia, vol.109, issue.2, pp.572-84, 2009.
DOI : 10.1213/ane.0b013e3181a85d0e

Y. Chen, B. Feng, and Z. Chen, Abstract, Experimental and Clinical Endocrinology & Diabetes, vol.120, issue.02, pp.116-136, 2012.
DOI : 10.1055/s-0031-1297968

URL : https://hal.archives-ouvertes.fr/hal-00780803

K. Node, M. Fujita, M. Kitakaze, M. Hori, and J. Liao, Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy, Circulation, vol.108, issue.7, pp.839-882, 2009.
DOI : 10.1161/01.CIR.0000084539.58092.DE

J. Larosa, S. Grundy, D. Waters, C. Shear, P. Barter et al., Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease, New England Journal of Medicine, vol.352, issue.14, pp.1425-1460, 2005.
DOI : 10.1056/NEJMoa050461

A. Ouattara, H. Benhaoua, L. Manach, Y. Mabrouk-zerguini, N. Itani et al., Perioperative Statin Therapy Is Associated With a Significant and Dose-Dependent Reduction of Adverse Cardiovascular Outcomes After Coronary Artery Bypass Graft Surgery, Journal of Cardiothoracic and Vascular Anesthesia, vol.23, issue.5, pp.633-641, 2009.
DOI : 10.1053/j.jvca.2009.02.008

E. Olafsdottir, T. Aspelund, G. Sigurdsson, R. Benediktsson, B. Thorsson et al., Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies, BMC Public Health, vol.93, issue.5, pp.36-23320535, 2013.
DOI : 10.1097/HJR.0b013e32825fea6d

S. Silva, P. Lourenço, C. Paulo, E. Ferreira, A. Lebreiro et al., Statin-Induced Low Cholesterol is Not Associated With Poor Outcome in Chronic Heart Failure, Journal of Cardiovascular Pharmacology and Therapeutics, vol.93, issue.3, pp.284-90, 2012.
DOI : 10.1016/j.amjcard.2004.01.039

S. Janda, A. Young, J. Fitzgerald, M. Etminan, and J. Swiston, The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis, Journal of Critical Care, vol.25, issue.4, pp.656-663, 2010.
DOI : 10.1016/j.jcrc.2010.02.013

H. Wemmelund, A. Høgh, H. Hundborg, R. Thomsen, S. Johnsen et al., Statin use and rupture of abdominal aortic aneurysm, British Journal of Surgery, vol.32, issue.Suppl, pp.966-75, 2014.
DOI : 10.1093/eurheartj/ehr333

Y. Birnbaum, Y. Ye, S. Rosanio, S. Tavackoli, Z. Hu et al., Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia?reperfusion injury, Cardiovascular Research, vol.65, issue.2, pp.345-55, 2005.
DOI : 10.1016/j.cardiores.2004.10.018

P. Balakumar, S. Kathuria, G. Taneja, S. Kalra, and N. Mahadevan, Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?, Journal of Molecular and Cellular Cardiology, vol.52, issue.1, pp.83-92, 2012.
DOI : 10.1016/j.yjmcc.2011.09.014

Y. Yu, K. Ohmori, Y. Chen, C. Sato, H. Kiyomoto et al., Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model, Journal of the American College of Cardiology, vol.44, issue.4, pp.904-917, 2004.
DOI : 10.1016/j.jacc.2004.04.050

W. Gu, F. Kehl, J. Krolikowski, P. Pagel, D. Warltier et al., Simvastatin Restores Ischemic Preconditioning in the Presence of Hyperglycemia through a Nitric Oxide???mediated Mechanism, Anesthesiology, vol.108, issue.4, pp.634-676, 2008.
DOI : 10.1097/ALN.0b013e3181672590

L. Kang, C. Ge, and S. Hu, Beneficial Effect of Atorvastatin on Left Ventricular Remodeling in Spontaneously Hypertensive Rats, Pharmacology, vol.80, issue.2-3, pp.2-3, 2007.
DOI : 10.1159/000103251

H. Beloeil, J. Mazoit, D. Benhamou, and J. Duranteau, Norepinephrine kinetics and dynamics in septic shock and trauma patients, British Journal of Anaesthesia, vol.95, issue.6, pp.782-790, 2005.
DOI : 10.1093/bja/aei259

S. Van-linthout, A. Riad, N. Dhayat, F. Spillmann, J. Du et al., Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy, Diabetologia, vol.65, issue.Pt 2, pp.1977-86, 2007.
DOI : 10.1161/01.CIR.100.2.178

Q. Dai, J. Lu, and N. Liu, Fluvastatin attenuates myocardial interstitial fibrosis and cardiac dysfunction in diabetic rats by inhibiting over-expression of connective tissue growth factor, Chin Med J (Engl), vol.124, issue.1, pp.89-94, 2011.

J. Martin, K. Connelly, A. Boyle, A. Kompa, Y. Zhang et al., Effect of Atorvastatin on Cardiac Remodelling and Mortality in Rats Following Hyperglycemia and Myocardial Infarction, International Journal of Cardiology, vol.143, issue.3, pp.353-60, 2010.
DOI : 10.1016/j.ijcard.2009.03.098

X. Zheng and S. Hu, Effects of simvastatin on cardiohemodynamic responses to ischemia???reperfusion in isolated rat hearts, Heart and Vessels, vol.15, issue.2, pp.116-139, 2006.
DOI : 10.1111/j.1476-5381.1995.tb16679.x

F. Xie, C. Sun, L. Sun, J. Li, X. Chen et al., Influence of fluvastatin on cardiac function and baroreflex sensitivity in diabetic rats, Acta Pharmacologica Sinica, vol.101, issue.3, pp.321-329, 2011.
DOI : 10.1080/14628840127765

U. Mühlhäuser, O. Zolk, T. Rau, F. Münzel, T. Wieland et al., Atorvastatin desensitizes betaadrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits

M. Ito, T. Adachi, D. Pimentel, Y. Ido, and W. Colucci, Statins Inhibit ??-Adrenergic Receptor-Stimulated Apoptosis in Adult Rat Ventricular Myocytes via a Rac1-Dependent Mechanism, Circulation, vol.110, issue.4, pp.412-420, 2004.
DOI : 10.1161/01.CIR.0000136088.18960.E6

S. Pugh, D. Macdougall, S. Agarwal, R. Harvey, K. Porter et al., Caveolin Contributes to the Modulation of Basal and ??-Adrenoceptor Stimulated Function of the Adult Rat Ventricular Myocyte by Simvastatin: A Novel Pleiotropic Effect, ): e106905. Pubmed Central PMCID: PMC4161364. https, p.25211146, 2014.
DOI : 10.1371/journal.pone.0106905.g010

Y. Sassi, A. Abi-gerges, J. Fauconnier, N. Mougenot, S. Reiken et al., Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes, The FASEB Journal, vol.26, issue.3, pp.1009-1026, 2012.
DOI : 10.1096/fj.11-194027

A. Carillion, S. Feldman, C. Jiang, F. Atassi, N. Na et al., Overexpression of Cyclic Adenosine Monophosphate Effluent Protein MRP4 Induces an Altered Response to ??-Adrenergic Stimulation in the Senescent Rat Heart, Anesthesiology, vol.122, issue.2, pp.334-376, 2015.
DOI : 10.1097/ALN.0000000000000526

R. Datar, W. Kaesemeyer, S. Chandra, D. Fulton, and R. Caldwell, Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx, British Journal of Pharmacology, vol.7, issue.7, pp.1765-72, 2010.
DOI : 10.1038/89986

S. Zaitone and N. Abo-gresha, Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: Role of iNOS and VEGF, European Journal of Pharmacology, vol.691, issue.1-3, pp.1-3, 2012.
DOI : 10.1016/j.ejphar.2012.06.022

J. Blanco-rivero, N. De-las-heras, B. Martín-fernández, V. Cachofeiro, V. Lahera et al., Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats, British Journal of Pharmacology, vol.123, issue.1, pp.271-85, 2011.
DOI : 10.1016/j.jep.2009.03.035

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012421

G. Kojda, K. Kottenberg, P. Nix, K. Schlüter, H. Piper et al., Low Increase in cGMP Induced by Organic Nitrates and Nitrovasodilators Improves Contractile Response of Rat Ventricular Myocytes, Circulation Research, vol.78, issue.1, pp.91-101, 1996.
DOI : 10.1161/01.RES.78.1.91

P. Mohan, D. Brutsaert, W. Paulus, and S. Sys, Myocardial Contractile Response to Nitric Oxide and cGMP, Circulation, vol.93, issue.6, pp.1223-1232, 1996.
DOI : 10.1161/01.CIR.93.6.1223

G. Oudit and J. Penninger, Cardiac regulation by phosphoinositide 3-kinases and PTEN, Cardiovascular Research, vol.82, issue.2, pp.250-60, 2009.
DOI : 10.1093/cvr/cvp014

C. Jiang, A. Carillion, N. Na, D. Jong, A. Feldman et al., Modification of the ??-Adrenoceptor Stimulation Pathway in Zucker Obese and Obese Diabetic Rat Myocardium*, Critical Care Medicine, vol.43, issue.7, pp.241-250, 2015.
DOI : 10.1097/CCM.0000000000000999

URL : https://hal.archives-ouvertes.fr/tel-01418221